Legal 500
Log in or register
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Legal 500 Trust Centre
  • Contact Us
  • home
  • Market Intelligence
  • Search

442 results found

Use advanced search filters to refine your search

2 filters applied

Advanced search filters

Topics
Countries
Contributor

Start typing to add contributors

Content type
Show options
  • Article

    Delhi High Court’s Decision On Teva Pharmaceutical’s Plaint Against Natco

    The Delhi High Court has returned Teva’s plea against NATCO seeking permanent injunction for restraining the manufacture of Glatiramer Acetate for sale in the US.
    IndiaIntellectual Property
    S&A Law Offices
    S&A Law Offices
  • Article

    Limitation Period Extension On Account Of Covid-19 Applies To Delay That Can Be Statutorily Condoned: Supreme Court Of India

    The Hon'ble Supreme Court in a recent order in Centaur Pharmaceuticals Pvt. Ltd. and Anr. v. Standford Laboratories Pvt. Ltd.
    IndiaLitigation, Mediation & Arbitration
    Phoenix Legal
Phoenix Legal
  • Article

    Kit of parts Claims: Indian position

    We normally come across many types of patent claims. A patent kit type claims refers to a claim where the inventor wants to patent the selling of two or more products together in a ‘kit' to be combined at the time of use only.
    IndiaIntellectual Property
    Lex Orbis
    Lex Orbis
  • Article

    Hydroxyethyl-Starch Solutions For Infusion To Be Suspended In The European Union

    On January 12, 2018, the European Medicines Agency's Pharmacovigilance Risk Assessment Committee recommended the suspension of the marketing authorizations for hydroxyethyl-starch solutions for infusion across the European Union.
    European UnionFood, Drugs, Healthcare, Life Sciences
    S&A Law Offices
    S&A Law Offices
  • Article

    Delhi High Court Strikes Down Notification Dated 10 March 2016 Issued By The Government Of India Banning 344 Fixed Dose Combination (FDC) Drugs

    FDCs are combinations of two or more active pharmaceutical ingredients in fixed ratios, given in the form of a single dose.
    IndiaFood, Drugs, Healthcare, Life Sciences
    Khaitan & Co.
    Khaitan & Co.
  • Article

    E-Pharmacy - Legal Sanctity?

    While the economy is witnessing a fast transition from "offline" to "online" markets and there is a sturdy buzz of "demonetization" and "one click" access to everything, . . .
    IndiaFood, Drugs, Healthcare, Life Sciences
    ARA LAW
    ARA LAW
  • Article

    Emerging Trends For Biologics And Biosimilars In India

    Beginning with the basics, biosimilars are biological products which are highly similar to or copies of approved biologics.
    IndiaFood, Drugs, Healthcare, Life Sciences
    Lex Orbis
    Lex Orbis
  • Article

    Food & Pharma Flash - March 2014

    Last year, Pharma sector witnessed major positive developments on the regulatory front.
    IndiaFood, Drugs, Healthcare, Life Sciences
    PSA
    PSA
  • Article

    New Drugs And Clinical Trials (Amendment) Rules, 2024

    The Ministry of Health and Family Welfare has on September 19, 2024, announced significant amendments to the New Drugs and Clinical Trials Rules, 2019 ("NDCT Rules, 2019").
    IndiaFood, Drugs, Healthcare, Life Sciences
    JSA Advocates & Solicitors
    JSA Advocates & Solicitors
  • Article

    Typical Issues Encountered In Deals Involving Hospitals

    Some authorities have issued separate handbooks in the context of the leased lands, which impose additional restrictions as well.
    IndiaFood, Drugs, Healthcare, Life Sciences
    AZB & Partners
    AZB & Partners
  • Article

    WHO Revises Advice On Delamanid Drug Usage In Multidrugresistant Tuberculosis (MDR-TB) Patients

    On January 15, 2018, the World Health Organization's (WHO) Global Tuberculosis Programme has released a Position Statement on the use of delamanid in treatment of multidrug-resistant tuberculosis (MDR-TB).
    IndiaFood, Drugs, Healthcare, Life Sciences
    S&A Law Offices
    S&A Law Offices
  • Article

    Sanitary Napkins v. Medicines: Delhi High Court On Dissimilar Goods In Same Class

    In the fiercely competitive world of trademarks, a single word or phrase can become a powerful symbol distinguishing a business, securing its reputation, and fostering loyalty among consumers
    IndiaIntellectual Property
    S.S. Rana & Co.
    S.S. Rana & Co.
  • Article

    India Newsletter - Quarter Of April To June 2022

    In this newsletter, INDUSLAW 日本のニュースレター brings you key legal, regulatory and policy updates from India (both sector-specific and general) for the recently concluded quarter.
    IndiaLitigation, Mediation & Arbitration
    CMS INDUSLAW
    CMS INDUSLAW
  • Article

    AI And Its Usage In Medical Field & Beyond: The Expanding Frontiers Of Legal Liability

    The application of artificial intelligence (AI) in the domains of medical science has introduced significant innovations that have improved the diagnosis of various kinds of disease...
    IndiaTechnology
    Maheshwari & Co. Advocates & Legal Consultants
    Maheshwari & Co. Advocates & Legal Consultants
  • Article

    CCI Exonerates RDCA Of Anti-Competitive Conduct In Pharmaceutical Market- Disagrees Again With Findings Of The DG

    After the investigation DG found that the RDCA was levying and collecting PIS charges in Mumbai.
    IndiaAntitrust/Competition Law
    Vaish Associates Advocates
    Vaish Associates Advocates
  • Article

    Legal Metrology (General) Third Amendment Rules, 2025: Regulating Automated Blood Pressure Devices In India

    The Ministry of Consumer Affairs, Food and Public Distribution has notified the Legal Metrology (General) Third Amendment Rules, 2025...
    IndiaConsumer Protection
    IndiaLaw LLP
    IndiaLaw LLP
  • Article

    Healthcare | September and October 2024 - Regulatory Updates

    On March 12, 2024, the Department of Pharmaceuticals ("DoP") introduced the Uniform Code for Pharmaceutical Marketing Practices...
    IndiaFood, Drugs, Healthcare, Life Sciences
    JSA Advocates & Solicitors
    JSA Advocates & Solicitors
  • Article

    Innovation & Societal Impact: An Analysis Of The DBT IP Guidelines 2023

    The Department of Biotechnology (DBT), under the Ministry of Science & Technology, recently notified that the DBT Intellectual Property Guidelines in September 2023.
    IndiaFood, Drugs, Healthcare, Life Sciences
    Intepat IP
    Intepat IP
  • Article

    Knowledge Management - Semi-Annual Healthcare Sector Compendium 2024

    This Compendium consolidates all key developments pertaining to the Healthcare sector which were circulated as JSA Newsletters/Prisms from January 2024 till June 2024.
    IndiaFood, Drugs, Healthcare, Life Sciences
    JSA Advocates & Solicitors
    JSA Advocates & Solicitors
  • Article

    Lifesciences And Healthcare Newsletter - April 2024

    Stay updated with the latest developments in the life sciences and healthcare sectors with our April 2024 newsletter.
    IndiaFood, Drugs, Healthcare, Life Sciences
    Dentons
    Dentons
  • Showing 221–240 of 442 results

    PreviousNext
    Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics